Hepatic Carcinoma: Clinical Trials

5 trials for Hepatic Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 2
Phase 12Unknown 2

Follow Hepatic Carcinoma: new trials by email Literature Review of Hepatic Carcinoma trials Research Report on Hepatic Carcinoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Octreotide, Placebo - Hepatic Carcinoma, Hepatic Metastasis
Phase 2UnknownClinica Universidad de Navarra, Universidad de Navarra622023-08-142023-10-17
to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve
Ga68-Dolacga Injection - Hepatic Carcinoma
Phase 2CompletedNational Atomic Research Institute, Taiwan302021-12-142023-12-13
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
Tumor infiltrating lymphocyte - Hepatic Carcinoma
Phase 1 / Phase 2UnknownCAR-T (Shanghai) Cell Biotechnology Co., Ltd.402020-08-262020-09-04
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
Nivolumab, TACE - Carcinoma, Hepatocellular, Hepatic Carcinoma
Phase 2CompletedAIO-Studien-gGmbH492018-06-142023-07-20
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
CAR-T cell immunotherapy - Colon Cancer, Esophageal Carcinoma
Phase 1 / Phase 2UnknownFirst Affiliated Hospital of Chengdu Medical College602017-01-012017-01-06

Narrower conditions

Carcinoma, Hepatocellular (5)  ·  Colonic Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Adenocarcinoma (5)  ·  Carcinoma (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Liver Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Liver Neoplasms (4)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Esophageal Diseases (1)

Interventions

Immunotherapy, Adoptive (1)  ·  Nivolumab (1)  ·  Octreotide (1)

Sponsors

AIO-Studien-gGmbH (1)  ·  CAR-T (Shanghai) Cell Biotechnology Co., Ltd. (1)  ·  Clinica Universidad de Navarra, Universidad de Navarra (1)  ·  First Affiliated Hospital of Chengdu Medical College (1)  ·  National Atomic Research Institute, Taiwan (1)

Countries

China (2)  ·  Germany (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Arndt Vogel, Prof.Dr. (1)  ·  Wei-Chen Lee, MD (1)  ·  Xiao-an Li, PhD (1)

Results publications

PMID 32557715

NIH funding

2017 (1)